# Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer

> **NCT05594082** · — · UNKNOWN · sponsor: **Fudan University** · enrollment: 150 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Trastuzumab Deruxtecan

## Key facts

- **NCT ID:** NCT05594082
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2023-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05594082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05594082, "Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05594082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*